Por favor, use este identificador para citar o enlazar este ítem: https://hdl.handle.net/11000/34669
Registro completo de metadatos
Campo DC Valor Lengua/Idioma
dc.contributor.authorGonzález Valdivieso, María-
dc.contributor.authorOrozco-Beltran, Domingo-
dc.contributor.authorLopez-Pineda, Adriana-
dc.contributor.authorGil-Guillén, Vicente F-
dc.contributor.authorQuesada, José A.-
dc.contributor.authorCarratala-Munuera, Concepcion-
dc.contributor.authorNOUNI GARCÍA, RAUF-
dc.contributor.otherDepartamentos de la UMH::Medicina Clínicaes_ES
dc.contributor.otherDepartamentos de la UMH::Patología y Cirugíaes_ES
dc.date.accessioned2025-01-16T18:29:24Z-
dc.date.available2025-01-16T18:29:24Z-
dc.date.created2022-
dc.identifier.citationJournal of cardiovascular pharmacology and therapeutics. 2022 Jan-Dec:27:10742484221078973es_ES
dc.identifier.issn1940-4034-
dc.identifier.issn1074-2484-
dc.identifier.urihttps://hdl.handle.net/11000/34669-
dc.description.abstractBackground: Atrial fibrillation (AF) is the most common arrhythmia to appear in clinical practice. People with AF have 5 times the risk of stroke compared to the general population. Objective: This study aimed to determine the prevalence of AF in people over the age of 50 without known AF, who presented to a community pharmacy to check their cardiovascular risk factors, to identify risk factors associated with AF, and to assess the risk of stroke in people who screened positive for AF. Methods: A multicenter observational descriptive study of a screening program took place from May to December 2016. A blood pressure monitor (Microlife Watch BP Home) was used to screen for AF, and the CHA2DS2-VASc questionnaire was used to assess stroke risk. Results: The study included 452 adults over the age of 50. The CRIFAFARMA study detected a prevalence of AF of 9.1%. Risk factors for AF were: age of 75 years or older (P = .024), lack of physical activity (P = .043), diabetes (P < .001), dyslipidemia (P = .003), and history of cardiovascular disease (P = .003). Diabetes (OR 2.79, P = .005) and dyslipidemia (OR 2.16, P = .031) had a combined explanatory capacity in the multivariable logistic regression model adjusted for age. 85% were at high risk of stroke according to the CHA2DS2-VASc scale. Conclusions: AF was detected in more than 9% of the included population. Factors associated with AF were advanced age, lack of physical activity, diabetes, dyslipidemia, and history of cardiovascular disease, with diabetes and dyslipidemia standing out as the factors with independent explanatory capacity.es_ES
dc.formatapplication/pdfes_ES
dc.format.extent9es_ES
dc.language.isoenges_ES
dc.publisherSAGE Publicationses_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectatrial fibrillationes_ES
dc.subjecthypertensiones_ES
dc.subjectpharmacistes_ES
dc.subjectcommunity pharmacyes_ES
dc.subjectMicrolife Watch BP Homees_ES
dc.titleEarly Detection of Atrial Fibrillation in Community Pharmacies-CRIFAFARMA Studyes_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publisherversion10.1177/10742484221078973es_ES
Aparece en las colecciones:
Artículos Patología y Cirugía


Vista previa

Ver/Abrir:
 Early Detection of Atrial Fibrillation in Community Pharmacies-CRIFAFARMA Study.pdf

168,64 kB
Adobe PDF
Compartir:


Creative Commons La licencia se describe como: Atribución-NonComercial-NoDerivada 4.0 Internacional.